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Exosomal HIF1α supports invasive potential of
nasopharyngeal carcinoma-associated LMP1-positive
exosomes
M Aga1,2, GL Bentz1, S Raffa3, MR Torrisi3, S Kondo2, N Wakisaka2, T Yoshizaki2, JS Pagano1,5 and J Shackelford1,4,5
It has emerged recently that exosomes are potential carriers of pro-tumorigenic factors that participate in oncogenesis. However,
whether oncogenic transcription factors are transduced by exosomes is unknown. Hypoxia-inducible factor-1α (HIF1α)
transcriptionally regulates numerous key aspects of tumor development and progression by promoting a more aggressive tumor
phenotype, characterized by increased proliferation and invasiveness coupled with neoangiogenesis. It has been shown that the
principal oncoprotein of Epstein–Barr virus (EBV), latent membrane protein 1 (LMP1), drives oncogenic processes and tumor
progression of the highly invasive EBV malignancy, nasopharyngeal carcinoma (NPC). We now demonstrate that endogenous HIF1α
is detectable in exosomes and that LMP1 significantly increases levels of HIF1α in exosomes. HIF1 recovered from exosomes retains
DNA-binding activity and is transcriptionally active in recipient cells after exosome uptake. We also show that treatment of EBV-
negative cells with LMP1-exosomes increases migration and invasiveness of NP cell lines in functional assays, which correlates with
the phenotype associated with epithelial–mesenchymal transition (EMT). In addition, we provide evidence that HIF1α itself
participates in exosome-mediated pro-metastatic effects in recipient cells, as exosome-mediated delivery of active and inactive
forms of HIF1α results in reciprocal changes in the expression of E- and N-cadherins associated with EMT. Further,
immunohistochemical analysis of NPC tumor tissues revealed direct correlation between protein levels of LMP1 and of the
endosome/exosome marker tetraspanin, CD63, which suggests an increase in exosome formation in this EBV-positive malignancy.
We hypothesize that exosome-mediated transfer of functional pro-metastatic factors by LMP1-positive NPC cells to surrounding
tumor cells promotes cancer progression.
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INTRODUCTION
Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy,
and 70–90% of patients present with cervical lymph-
node metastasis at the time of initial diagnosis. As the bio-
logical behavior of NPC depends on its nodal status, patients
with advanced nodal disease are likely to have a poor
outcome, and drug resistance may hamper the efficacy of
anticancer drugs.1
Virtually, all NPC are infected with Epstein–Barr virus (EBV).2 EBV
produces latent infection of NPC cells, which persists in the form
of EBV episomes. Occasionally, there is sporadic viral reactivation
and lytic infection in a few NPC cells. Generally, Type II latency is
maintained, and thus EBV-gene expression is restricted to EBNA1,
latent membrane protein 1 (LMP1), LMP2, EBERs and BART-
encoded miRNAs.3 The EBV primary oncogene LMP1 is expressed
in NPC tumor tissue and has been shown to induce transforma-
tion, inhibit differentiation and promote migration of epithelial
cells. In addition to an etiological role in EBV malignancies, there is
circumstantial evidence to suggest that LMP1 also promotes
tumor progression by enhancing expression of invasion and
metastasis factors.3 LMP2 also contributes to oncogenesis and
tumor maintenance.2
Invasion and metastasis are determinative features in the
pathogenesis and progression of malignant neoplasms. The
process of metastasis consists of multiple, sequential, selective
and interdependent steps. As noted, early metastasis directly to
regional lymph nodes is common in NPC. To establish a distant
metastatic focus, tumor cells must detach from the primary tumor
(suppression of cell-to-cell and cell–matrix adhesion), degrade and
invade extracellular matrix, increase cell motility and enter the
circulation, where they are arrested in capillary beds and gain
entrance to organ parenchyma, proliferate and induce angiogen-
esis. It is now well established that the processes of invasion and
angiogenesis are essential to promote and sustain metastases of
both primary and metastatic tumors. Furthermore, the epithelial-
to-mesenchymal transition (EMT), characterized by the loss of
epithelial characteristics and the gain of mesenchymal attributes
in epithelial cells, is clearly associated with pathological processes
requiring epithelial cell migration and invasion.4
We identified the type IV collagenase matrix metalloproteinase-
9 as a key molecule in the destruction of extracellular matrix that is
upregulated by LMP1 via nuclear factor-κB and activator protein-1
signaling pathways. Additionally, LMP1 induces mucin 1 and
the membrane crosslinker protein ezrin in early steps of cell
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detachment. Moreover, LMP1 can induce EMT via Twist or Snail,
which coincides with the acquisition of cancer stem-cell proper-
ties. Recently, special AT-rich-binding protein 1, a global regulator
of chromatin remodeling and gene expression, has been
identified as a pro-metastatic effector of LMP1 signaling in EBV-
positive NPC. We have also shown that LMP1 induces
cyclooxygenase-2 and hypoxia-inducible factor-1α (HIF1α), which
have key roles in the induction of vascular endothelial growth
factor and finally angiogenesis.5
The transcriptional activator HIF16 is the key mediator of the
cellular responses to hypoxia and controls the expression of at
least 40 genes that are involved in angiogenesis, invasion and
metastasis of cancer. HIF1 consists of two subunits: HIF1α and
HIF1β (or ARNT). Both contain basic helix loop helix and PER-
ARNT-SIM (PAS) domains in their NH2-terminal regions that
mediate heterodimerization and binding to DNA regulatory
sequences. These sequences, called hypoxia response elements
(HREs), are present in the promoter or enhancer regions of HIF1
target genes. Under normoxic conditions, HIF1α is ubiquitinated
by Von Hippel Lindau E3 ligase for proteasome degradation in
cytoplasm. Once stabilized, HIF1α translocates to the nucleus
guided by a nuclear localization signal present in its C-terminus.
HIF1 heterodimers directly induce the expression of Twist by
binding to HREs in the Twist proximal promoter region and
promote EMT and metastatic phenotype.6 As ~ 90% of NPC are
undifferentiated (World Health Organization type III), EMT is
expected to be a key feature in the oncogenesis of NPC.
Previously, we found a relation between LMP1 and increased
HIF1α expression in both lymphoblastoid and epithelial cell lines.7
Subsequently, we showed the mechanism by which LMP1
functions in this content: it stabilizes seven in absentia homolog1,
an E3 ubiquitin ligase, which in turn ubiquitinates and destabilizes
prolyl hydroxylase proteins (PHD1 and PHD3) that, under
normoxic conditions, are responsible for hydroxylation and
subsequent degradation of HIF1α.8 In this manner, LMP1
expression effectively increases HIF1α levels leading to down-
stream transcription of angiogenic factors.
Exosomes are small vesicles (40–100 nm in diameter) originat-
ing from late endosomes and multivesicular bodies (MVBs), and
they are secreted into the extracellular milieu after fusion of MVBs
with the plasma membrane.9 Exosomes contain lipids, pro-
teins and RNAs,10 and whereas some of these molecules represent
obsolete cargo targeted for extracellular destruction, certain
proteins and mRNAs exported by exosomes carry signaling-
relevant information.11 Therefore, exosomes have recently been
implicated in initiation and progression of many diseases,
including cancer.12 Exosomes can transfer invasion and metastasis
factors to uninfected cells and produce cellular changes char-
acteristic of tumor progression,13 and functional delivery of LMP1
to target cells via exosomes has also been described.14 However,
the mechanism of exosome formation, secretion and uptake, as
well as the physiological significance of exosomal content remain
to be understood.15
A large family of membrane receptors, tetraspanins, has been
proposed to have major function in exosome formation and
release.16 For example, expression of the tetraspanins CD9 or CD82
induces exosomal sorting and secretion of β-catenin from cells,17
and tetraspanins CD63 and CD81 have been shown to bind
components of the exosomal sorting machinery.18 Tetraspanins,
palmitoylated in the Golgi complex,19 form homodimers, which are
subsequently transported to the cell surface, where they function
as building blocks for tetraspanin-enriched microdomains.20 Late
endosomes/MVBs can be triggered to fuse with the cell surface
and release their intraluminal vesicles. Along with several other
proteins such as Flotillin2 and HSC70, the tetraspanins CD63 and
CD9 are commonly used markers for exosomes.21,22
Recent reports suggest that tumor viruses such as EBV and
KSHV manipulate the tumor microenvironment through the
secretion of specific viral and cellular components into
exosomes.23 The exosomes produced by EBV-infected NPC cells
contain high levels of LMP1 and viral microRNAs that activate
critical signaling pathways in recipient cells,14 and the EBV primary
oncogene LMP1 promotes secretion of pro-invasive fibroblast
growth factor 2 through exosomes.24 Here, for the first time, we
demonstrate that the pro-metastatic transcription factor HIF1 is
abundantly secreted from NPC cells expressing LMP1 by
endocytosis/exocytosis. Moreover, exosomal cell-to-cell transmis-
sion of transcriptionally active HIF1α correlated with EMT-
associated changes in the cadherin expression profile in recipient
cells. We propose that LMP1-positive exosomes promote progres-
sion of NPC by increasing its invasive potential and that
transcription factor HIF1 participates in this process.
RESULTS
The EBV oncogene LMP1 increases endogenous levels of the
transcription factor HIF1α in exosomes secreted by NP cells
It is becoming increasingly clear that exosomes participate in
distinct biological processes, including invasion and metastasis.13
As reports of the number and physiological spectrum of cellular
molecules transferred intercellularly within exosomes are
growing,12 we asked whether transcription factors with multi-
functional effects such as HIF1α might be among important pro-
invasive factors transferred from donor to recipient cells by LMP1-
positive exosomes. To test this hypothesis, we analyzed exosomal
fractions from both stably LMP1-expressing NP69 and LMP1
transiently transfected AdAH nasopharyngeal cells for the
presence of HIF1α. To purify exosomes from the culture super-
natant fluids, we used sequential centrifugation.14 Figure 1a (left
panel) shows that exosomal fractions from LMP1-NP69 cells
contain relatively high levels of HIF1α compared with exosomes
from parental, LMP1-negative NP69 cells. Additionally, although
we detected certain levels of HIF1α in exosome fractions from
nasopharyngeal AdAH cells, there was a significant increase in the
amount of HIF1α after transient transfection with LMP1 as
illustrated in Figure 1a (right panel). Total protein lysates of
pellets from the supernatant fluids were normalized for specific
exosomal markers HSC70 and flotillin 2. These results indicate that
exosomes from transformed NP cells contain endogenous HIF1α
and that the EBV primary oncogene LMP1 upregulates amounts of
the factor detected in the exosomes.
We next examined the purified fractions by transmission
electron microscopy (Figure 1b). Negative staining revealed
vesicles 60–100 nm in diameter (Figure 1b, upper panel) with
double membranes—characteristics specific for exosomes.26 Then
we performed transmission electron microscopic analysis of the
same exosomal nanoparticles with HIF1α primary and colloidal
gold-labeled secondary antibodies (Figure 1b, bottom panel).24
HIF1α was detected inside exosomes from both the cell types
examined: LMP1-NP69 and 293T cells transfected with
HIF1α expression vectors. Therefore localization of HIF1α to
exosomes is not exclusive to nasopharyngeal cells and is expected
to be found in exosomes secreted by different types of
transformed cells. In addition, we confirmed the correlation
between LMP1 and HIF1α levels after exosome uptake in recipient
cells: Figure 1c demonstrates that after the LMP1-negative NP cells
were exposed to graduated amounts of LMP1-positive exosomes
there was a dose-dependent increase of endogenous HIF1α in
recipient cells as well.
Exosomal HIF1α maintains DNA-binding activity and is
transcriptionally active in the recipient cells
Our previous studies demonstrate that LMP1 upregulates HIF1α
expression levels in nasopharyngeal cells.7 Therefore the increase
in HIF1α endogenous protein levels observed in recipient cells
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after treatment with LMP1-positive exosomes (Figure 1) could be
caused indirectly by LMP1-mediated upregulation of HIF1α
already expressed in the recipient cells. To begin establishing a
direct, LMP1-independent role of HIF1α in exosome-mediated
changes in recipient cells we asked: is HIF1α transferred by
exosomes transcriptionally active in recipient cells?
To answer this question, we utilized two HA-tagged HIF1α
expression vectors; wild-type (WT) HIF1α and a deletion mutant of
HIF1α that functions in a dominant-negative fashion: DN-HIF1α.27
Western blotting and luciferase reporter analyses in transiently
transfected 293T (LMP1-negative) host cells show relatively equal
expression of WT HIF1α and DN-HIF1α proteins and, as expected,
inhibition of transcriptional activity induced by the DN HIF1α
compared with WT HIF1α (Figure 2a). We next analyzed the
exosome fractions from the same transfected 293T host cells for
HA-tagged proteins. Figure 2b shows readily detectable levels of
both WT and DN HA-HIF1α as well as exosome markers flotillin2
and HSC70. Next, we analyzed transcriptional activity of exosomal
WT HIF1α and DN mutants in the recipient cells after treatment
with the exosomes obtained from the cells transfected with WT
and DN HIF1α. The results of the luciferase assays in Figure 2c
show that HIF1α activity is markedly reduced in the recipient cells
after uptake of DN HIF1α-containing exosomes. In addition, to
investigate whether HIF1 presence in exosomes affects its DNA-
binding ability, we performed in vitro electrophoretic mobility shift
assay with exosomal HIF1 from 293T cells transfected with
pcDNA3 or HA-HIF1α and oligonucleotides corresponding to
HRE sequence from the Twist promoter (Figure 2d). Detection of
DNA complexes with SYBR green DNA stain and western blotting
analysis with HIF1α antibody showed that incubation of exosome
fractions from HIF1α-transfected cells resulted in motility shift of
the HRE/HIF1 complex, indicating that exosomal HIF1 specifically
binds to the HRE DNA sequence. Taken together, the results in
Figure 2 clearly demonstrate that the functionality of HIF1α
present in exosomes is preserved.
Endogenous cytoplasmic HIF1α is associated with CD63-positive
late endosomes
Exosomes derive from cellular compartments collectively named
‘late endosomes’ or ‘multivesicular bodies'. The member of the
tetraspanin protein family CD63 is abundant in MVBs and cycles
between these compartments and the exocytic pathway.28 As a
result, CD63 is one of the most reliable markers for MVBs.29 We
detected endogenous HIF1α in exosomes produced by the LMP1-
positive NP69 cell line (Figure 1), and because exosomes are
released from the lumina of late endosomes/MVBs, we should be
able to detect HIF1α in late endosomes as well. Indeed, we
detected endogenous HIF1α in at least some of the late
endosomal structures in NP69 cells as determined by co-
localization with CD63—a marker of both exosomes and MVBs
and shown by arrows in Figure 3a.
Direct correlation between MVB marker and LMP1 expression
levels in NPC tissue samples
Based on our observation that more HIF1α is present in exosomes
from LMP1-positive cells (Figure 1a), and as the exosomes are
formed by reverse budding of the membrane of MVB, we next
analyzed possible correlation between LMP1 and MVBs levels
in vivo in NPC tissues. Immunohistochemical analysis of MVB
marker CD63 and LMP1 was performed in NPC specimens
obtained from 20 patients (Figure 3b). The mean expression
scores for CD63 and LMP1 were 21.85 ± 24.45% and
12.05 ± 16.17%, respectively. Expression scores for CD63 and
LMP1 are closely correlated (r= 0.7153; Po0.001). Taken together,
our data on the association of endogenous HIF1α with MVB
marker in an LMP1-positive NP cell line (Figure 3a), and the
correlation between LMP1 and MVB marker in NPC tissues
(Figure 3b), imply that LMP1 might upregulate exocytosis during
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Figure 1. The EBV oncogene LMP1 increases endogenous levels of
the transcription factor HIF1α in exosomes secreted by NP cells.
(a) Purified exosomal fractions from NP69 cells stably expressing
LMP1 or the control and AdAH nasopharyngeal cells transiently
transfected with LMP1 or a control-expression vector were analyzed
by immunoblotting. Total protein lysates of exosome pellets, isolated
from supernatant fluids, were normalized to exosome-specific markers
HSC70 and flotillin2. (b) Purified exosomes from NP69-LMP1 and 293T
cells transiently transfected with HIF1α expression plasmids were
subjected to ultrastructural examination and immunogold labeling for
HIF1α. Exosomes were stained with HIF1α primary and colloidal gold-
labeled secondary antibodies. (c) LMP1-negative AdAH cells were
treated with graduated amounts of exosome fractions isolated from
LMP1-expressing AdAH cells. After 24 h, western blotting analyses
were used to detect LMP1, HIF1α and GAPDH (glyceraldehyde
3-phosphate dehydrogenase) expression in recipient AdAH cells.
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LMP1-positive exosomes and exosomal HIF1α change expression
of EMT markers in recipient cells
LMP1 upregulates each step of metastasis and contributes to the
highly metastatic character of NPC.5 Also, recent studies indicate
that cancer-derived exosomes can signal activation of genes that
promote cancer invasion and metastasis.13 As LMP1 induces EMT
in NPC,5 we first investigated whether LMP1-positive exosomes
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Adhesion molecules are of crucial importance in cancer invasion
and metastasis and a major characteristic of EMT is reduction in
E-cadherin and increase in N-cadherin expression.30 Western
blotting analysis revealed that, after the treatment with LMP1-
positive exosomes, recipient cells expressed less E-cadherin and
more N-cadherin (Figure 4a), which is consistent with EMT-
associated phenotype. Furthermore, Figure 4b shows that the
increase in endogenous levels of N-cadherin, along with expected
morphological spindle-like changes in cell shape, occurred
explicitly in cells that acquired exosomes from Flag-LMP1-
transfected cells, which was determined by co-staining the
recipient cells with Flag and N-cadherin antibodies (Figure 4b).
Next, to distinguish the role of HIF1α transcriptional activity in
exosome-mediated changes in E- and N-cadherin expression
levels in NP cells, we once more utilized WT and DN HIF1α. As
shown in Figure 4c, exosomes with WT HIF1α from transfected
293T cells increased the levels of N-cadherin and decreased levels
of E-cadherin in recipient cells, whereas an inactive deletion
mutant of HIF1α from exosomes induced the opposite effect
(Figure 4c, second and third lanes). Taken together, the results in
Figure 4 demonstrate first that LMP1-positive exosomes induce
EMT-associated marker in recipient NP cells and second that active
HIF1α is likely to be a part of such exosome-mediated changes.
LMP1-positive exosomes increase migration and invasiveness of
NP cells in functional motility assays
To determine whether the upregulation of EMT-associated
markers by LMP1-positive exosomes has physiological conse-
quences, we utilized two cell culture assays commonly used to
analyze cell motility and invasiveness: the scratch (wound/healing)
assay and the migration of cells in extracellular matrix (Matrigel)
assay. Figure 5a demonstrates that migration of both LMP1-
negative NP69 and AdAH cell lines on the surface after scratching
was significantly increased by exposure to the LMP1-exosomes.
Moreover, we obtained concordant results in the trans-migration
assay as well. LMP1-exosome uptake stimulated trans-migration of
LMP1-negative NP cells into Matrigel (Figure 5b). Although
exosome treatment is likely to change many cellular processes
such as cell cycle progression, we found fewer exosome-treated
cells after 24 h in the upper chamber compared with the control,
untreated cells. Hence, our findings suggest that the cargo
molecules, such as HIF1 in the LMP1-positive exosomes, specifi-
cally change cell motility. Taken together, these results support
our hypothesis that exosomes secreted by LMP1-positive cells
participate in pro-metastatic progression of EBV-positive NPC,
presumably through the induction of EMT.
DISCUSSION
The main function of exosomes is intercellular communication,
which can result in redirection of signaling pathways in recipient
Figure 2. Exosome-mediated transfer of functionally active HIF1α to recipient cells. (a) 293T cells (LMP1-negative) were transfected with
pcDNA3 control and HA-tagged WT or HA-tagged DN HIF1α expression vectors along with HRE-luciferase reporter plasmid (see Materials and
methods). Luciferase assays for HIF1α activity and western blotting for determination of HA-tagged proteins were performed 24 h
post transfection. (b) Exosomes from the same transfected cells were purified, as described in Materials and methods. The presence of HIF1α
WT and DN mutant in exosomes was determined by western blotting with HA-tag antibodies. Exosomal fractions were normalized to HSC70
and flotillin2 (exosomal markers). (c) Recipient 293T cells were transfected with HRE-luciferase reporter and exposed to purified control, WT or
DN HIF1α-positive exosomes as described in panel (b). Twenty-four hours later, luciferase assays were performed and normalized to
β-galactosidase activity. The mean s.ds. were determined for experiments performed in triplicate. (d) The DNA-binding capacity of exosomal
HIF1α was determined by in vitro electrophoretic mobility shift assay (EMSA): exosome protein fractions were incubated with HRE probe
(see Materials and methods) according to the BD manufacturer’s protocol and separated by non-denaturating 6% PAGE. To detect shifts of
HRE–HIF1 complexes, the gel was stained with SYBR green EMSA to visualize DNA (left), and after transfer, the membrane was probed with
HIF1α antibodies for specific identification of exosomal HIF1 in complex with the HRE promoter (top right). Coomassie staining was used for





Figure 3. Physiological correlation between MVB marker and LMP1/
HIF1α levels. (a) LMP1-positive NP69 cells were fixed in 4%
paraformaldehyde and co-stained with the late endosome (MVB)
marker CD63 (green) and HIF1α (red). Shown are representative
images. (b) Direct correlation between MVB marker and LMP1
expression levels in NPC tissue samples was determined. Represen-
tative images of immunohistochemical analysis of paraffin-
embedded NPC specimens with CD63 (top, left) and LMP1 (top,
right) antibodies are presented. Dark-brown staining indicates CD63
and LMP1, respectively. In addition, expression scores for CD63 and
LMP1 in 20 NPC tissue specimens (see Materials and methods) were
determined. Average percentages of tumor cells staining for LMP1
and CD63 are plotted. Linear regression analyses were used to
ascertain the correlation between CD63 and LMP1 expression levels
(bottom).
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cells after exposure to the exosomes.11 Previous studies show that
the viral oncogene LMP1 as well as EBV microRNAs can be
transmitted from cell to cell by exosomes,31 and such transmission
is associated with EBV-induced oncogenesis.32
Reports of the variety of biologically active molecules that can
be transported intercellularly by exosomes are increasing.11
Indeed, exosomes secreted by virally infected cells contain >100
biologically active molecules.23 Although viral DNA and micro-
RNAs have been consistently detected in the peripheral blood of
NPC patients, the first evidence physiologically connecting EBV-
positive NPCs to exosomes came from observations showing that
exosomal fractions from the saliva, serum and plasma of NPC
patients contain EBV LMP1 and BARF1 oncoproteins.32 Further
studies demonstrated that LMP1-positive exosomes from latently
EBV-infected cells can transfer many signaling molecules to the
recipient cells.33 However, the present study is the first to reveal
and analyze the presence of a key pro-metastatic transcriptional
factor HIF1α in LMP1-exosomes (Figure 1). Most importantly, our
observations demonstrate biological activity of this transcriptional
factor after exosomal delivery to the recipient cells (Figure 2).
There is indirect evidence of involvement of HIF1α in exosomal
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Figure 4. LMP1-positive exosomes and exosomal HIF1α change expression of EMT markers in recipient cells. (a) LMP1-negative NP cells were
exposed to purified exosomes secreted by LMP1-positive and -negative cells. Twenty-four hours later, expression levels of endogenous HIF1α,
E-cadherin and N-cadherin were determined in recipient cell lysates by western blotting analyses. GAPDH (glyceraldehyde 3-phosphate
dehydrogenase) levels served as loading control. (b) AdAH cells were incubated with LMP1-expressing exosomes from Flag-LMP1-transfected
cells for 24 h, and then the cells were fixed and stained with Flag and N-cadherin antibodies (×20 (top) and× 40 (bottom) magnification,
respectively). The Flag staining (red) indicates the delivery of the exosomal cargo to the recipient cells. The absence of the Flag staining served
as a negative control for exosomal uptake. Anti-N-cadherin (green) staining shows the increase in N-cadherin endogenous levels in the cells
that received the exosomes. (c) Recipient 293T cells (LMP1-negative) were exposed to purified exosomes secreted by cells transfected with
control, WT HIF1α and DN HIF1α vectors. Exosome-mediated delivery of HIF1α proteins to recipient cells was evaluated by staining with HA-
tag antibodies. Changes in endogenous E- and N-cadherin protein levels in recipient cells after exosome uptake were analyzed with the
corresponding antibodies.
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hypoxia-regulated mRNAs and proteins.34 The secretion of
exosomes under hypoxic conditions within the placenta is
associated with proliferation and invasion of extravillous
trophoblasts.35 In addition, HIF1α initiates tumor necrosis factor-
α exosome-mediated secretion under hypoxic conditions.36 The
localization of HIF1α to exosomes does not depend on the viral
oncogene, because it is detectable in exosomal fractions of LMP1-
negative cells as well, but the presence of LMP1 significantly
increases the amount of HIF1α in these extracellular structures
(Figure 1).
As the intracellular sources of exosomes are MVBs, we also
demonstrate the presence of endogenous HIF1α in these
cellular structures in NP cells (Figure 3a). The findings indicate a
specific mechanism for sorting HIF1α to MVBs, distinct from
targeting for destruction by lysosomes. So far, several hypo-
theses have been proposed for MVB-mediated mechanism of
exosomal cargo formation,37–39 but the precise mechanism
remains to be determined. It has been shown recently that
regulatory ubiquitination is required for export of PTEN
tumor suppressor to exosomes.40 A similar mechanism might be
involved in exosomal intake of HIF1α as well. In addition, a
possible role for LMP1 in exosome biogenesis cannot be
eliminated. Our analyses also revealed the correlation between
LMP1 and CD63 levels in NPC tissues (Figure 3b). In the future, we
plan to investigate specific mechanisms of exosome formation
and cargo transfer in metastatic LMP1-positive NPC. Taken
together, our data on the association of endogenous HIF1α with
MVB marker in an NP cell line (Figure 3a), and the correlation
between LMP1 and MVB marker in NPC tissues (Figure 3b), imply
that LMP1 might regulate the processing of exosomes during NPC
metastatic progression.
In this study, we show that LMP1-positive exosomes (Figures 4a
and b) and HIF1α specifically (Figure 4c) can counterbalance the
levels of E- and N-cadherin in the recipient cells, consistent with
EMT-associated changes. More importantly, we demonstrate in
two different assays that exposure of non-malignant NP cells to
LMP1-positive exosomes with high levels of pro-metastatic factor
HIF1α increases the motility of the NP cells and thus enhances
their invasive potential (Figure 5). Recent reports indicate
that tumor-secreted exosomes manipulate the metastatic
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Figure 5. LMP1-positive exosomes increase motility and invasiveness of NP cells in functional assays. (a) Sub-confluent LMP1-negative AdAH
and NP69 cells that had been incubated with or without LMP1-expressing exosomes were scratched and cultured for 24 h. The widths of the
‘wound’ (scratched areas) were measured by ImageJ software (http://rsb.info.nih.gov/ij/), and the percentage of the wound healed was
calculated by the following formula: ‘wounded area filled (%)’= 100%− (width after 24 h/width at beginning) × 100% as shown in the
histogram. At left is a representative image of AdAH control and LMP1-exosome-treated cells 0 and 24 h after the scratch was applied
(*Po0.01, T-test). (b) The suspension of NP69 and AdAH cells incubated with or without LMP1-expressing exosomes was added to the insert
of a transwell cell-culture chamber containing Matrigel and incubated for 24 h. Medium containing 10% fetal bovine serum was added to the
bottom of the chamber. Cells that attached to the underside of the membrane were fixed and counted, and the average number of cells per
field of view was determined (mean± s.d.; n= 3; *Po0.01, T-test). At left, representative images of control and LMP1-exosome-treated AdAH
cells that invaded into the Matrigel after 24 h, stained with crystal violet.
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cascade through angiogenesis, stromal remodeling and signal
transduction by growth factor/receptor transfer, chemoresistance
and genetic intercellular exchange.41 HIF1 is likely not the only
transcription factor involved in these metastatic exosome-
mediated effects (although so far we did not detect in exosomal
fractions other possible candidates, such as Twist or Snail
transcription factors).
From the perspective of the other physiological roles of LMP1-
exosomes in the malignant properties of oncogenesis of NPC, we
also suggest that the cargo of the LMP1-positive exosomes
(including HIF1) transmits pro-metastatic signals to surrounding
cells as well. Malignant tumors are a complex of histopathological
features that consist of cancer cells and stroma.42 It is likely that
exosome-mediated transfer of pro-metastatic factors is one of the
major ways for highly invasive EBV-positive NPC cells to induce
EMT-like changes in tissues surrounding tumors. Continuous
crosstalk between cancer cells and local as well as distant host
environment is required for aggressive tumor growth and
systemic dissemination.43
In summary, rapidly emerging evidence indicates that exo-
somes may well have pivotal roles in local and systemic cell–cell
communication in the progression of nasopharyngeal cancer.32
Thus the major implication of the recent data is that LMP1-
exosomes affect NPC stromal components as well as tumor cells
themselves during invasion and metastasis. Pro-metastatic tran-
scription factors in exosomes such as HIF1α secure immediate
changes in the expression of sets of genes in recipient cells.
Hence, HIF1α-containing LMP1-exosomes offer not only new
opportunities for biomarker analysis but may also represent
targets for therapeutic intervention in metastatic NPC.
MATERIALS AND METHODS
Cell culture
Ad-AH cells, an EBV-negative human NPC (NP) cell line, were kindly
provided by Dr Erik K Flemington (Tulane University, New Orleans, LA, USA)
and maintained in DMEM (Dulbecco’s modified Eagle’s medium). NP69 and
NP69LMP1, human immortalized NP epithelial cells, generous gifts from Dr
Sai Wai Tsao (University of Hong Kong, Hong Kong, China), were
maintained in keratinocyte serum-free medium. All cells were maintained
at 37 °C in 5% CO2. Human embryonic kidney 293T cells were maintained
in DMEM.
Antibodies
Antibodies were purchased as indicated: HIF1α, N-cadherin, GAPDH, CD63,
HA and anti-HSC70 (from Santa Cruz Biotechnology, Santa Cruz, CA,
USA); and E-cadherin and anti–flotillin-2 (from BD Biosciences, San Jose,
CA, USA). S12 anti-LMP1 antibody was obtained from supernatant fluid of
a hybridoma produced by and the generous gift of David A Thorley-
Lawson (Tufts University).
Plasmids
pcDNA3-based LMP1 has been previously described.7 HA-HIF1α and HRE
reporter plasmid were purchased from Addgene (Cambridge, MA, USA)
(Plasmid 26731). Luciferase reporter construct containing three HREs (HRE:
TGTCACGTCCTGCACGACTCTAGT) was from the Pgk-1 gene. HA-DNHIF1α
was a gift from Darren E Richard.
Immunofluorescence microscopy
Cells cultured on glass coverslips were fixed with 4% paraformaldehyde,
washed with phosphate-buffered saline (PBS), permeabilized with 0.5%
Triton X-100/PBS and blocked with 1% normal donkey serum. Cells were
then incubated with primary antibodies overnight and were the same as
used for western blotting.
Western blotting analysis
Total cell lysates were denatured in sodium dodecyl sulfate (SDS) (Sigma,
St Louis, MO, USA) loading buffer and boiled for 5 min. Samples were
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to polyvinylidene fluoride (PVDF) membranes (General Electric,
Fairfield, CT, USA). Membranes were blocked with 5% milk in Tris-buffered
saline–Tween 20 (TBST) and incubated overnight at 4 °C with primary
antibodies. Membranes were then washed and incubated with appropriate
horseradish peroxidase-conjugated secondary antibodies for 1 h at room
temperature. Membranes were washed again, and bands were visualized
with enhanced chemiluminescence reagent from GE.
Transient transfection and Luciferase assays
293T cells were grown in six-well plates and transfected with 1 μg of
plasmids with the use of polyethylenimine (VWR, Radnor, PA, USA). Empty
vector was used to equalize total amounts of DNA in the transfections.
β-Galactosidase served as a transfection control. Luciferase and
β-galactosidase assays were performed 24 h posttransfection.
Exosome isolation and transfer
293T cells were grown to confluent monolayers and grown in culture for
an additional day. Exosomes were collected by differential centrifugation
from conditioned media, resuspended into PBS and stored at− 80 °C until
use.25 Cell monolayers were washed twice with PBS and incubated with
purified exosomes for the indicated times at 37 °C in serum-free media.
Cells exposed to exosomes were washed three times with PBS, scraped
into cold PBS, pelleted and lysed in PBS. HRE-luciferase plasmid and
β-galactosidase plasmid were transfected into 293T cells before exposure
to exosomes.
Invasiveness and wound-healing assays
For invasiveness assays, Matrigel was purchased from BD Biosciences and
stored at− 20 °C. Matrigel invasiveness assays were carried out according
to the manufacturer's instructions. The cell suspension with or without
exosomes from LMP1-expressing cells was added to the upper chamber of
a six-well transwell cell culture chamber and was incubated for 24 h with
medium containing 10% fetal bovine serum in the bottom of the chamber.
Cells adherent to the lower surface of filters were fixed and stained, and
cells invading through the Matrigel-coated membrane were counted. For
wound-healing assays, confluent cell monolayers incubated with or
without exosomes from LMP1-expressing cells were scratched with a
micropipette tip, and spontaneous cell migration was monitored for 24 h.
The widths of the ‘wound’ (scratched areas) were measured by ImageJ
(http://rsbweb.nih.gov/ij/), and the proportion of wound healing was
calculated by the following formula: 100%− (width after 24 h/width at the
beginning) × 100%.
Immunoelectron microscopy
Exosome-containing pellets obtained by ultracentrifugation were fixed
with 4% paraformaldehyde in PBS for 2 h at room temperature and then
resuspended in 2% paraformaldehyde in PBS. Droplets of this exosomal
fraction were directly spotted onto Formvar/carbon-coated copper grids
(100 meshes) and incubated with anti-HIF1α monoclonal antibody.
After several rinses in PBS-0.1% bovine serum albumin, the grids were
incubated with 18-nm diameter colloidal gold particles (prepared by citrate
method) conjugated with protein A (Pharmacia, Uppsala, Sweden)
and diluted in 1% bovine serum albumin in PBS. Control experiments
were performed by omission of the primary antibodies from the labeling
procedure. Finally, grids were stained with a solution of 2% methyl
cellulose and 0.4% uranyl acetate before examination by transmission
electron microscopy.24
Electrophoretic mobility shift assay
Mobility shift assays (Invitrogen, Carlsbad, CA, USA, E-33075) were
performed with the following double-stranded oligonucleotides contain-




TGAGACTCGC-3′. This oligonucleotide was generated using single-
stranded oligonucleotide. The oligomers (3 mg/ml) were annealed to
complementary oligomer in 3mM sodium citrate, pH 7.0 and 30mM NaCl at
95 °C for 5 min and then cooled slowly to room temperature for several
hours. The annealed oligomers were incubated with exosomes from 293T
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cells transfected with pcDNA3 or HA-HIF1α in the presence of 5 ×binding
buffer (Invitrogen; E33075) for 20min at room temperature. At the end of
the reaction, DNA loading dye was added, and the reaction was separated
on 6% PAGE in TAE buffer at 200 V. The gel was then stained with SYBR
green DNA stain for 20min, washed with double-distilled H2O and
visualized with a fluorescence imager (Kodak, Rochester, NY, USA). Next, for
detecting HIF1α, proteins were transferred onto PVDF membrane, and
western blotting analysis was performed for HIF1α with anti-HIF1α
antibody.
Immunohistochemical analysis of NPC tissues
Twenty selected NPC paraffin-embedded specimens from Kanazawa
University Hospital (Ishikawa, Japan) and Toyama Prefectural Central
Hospital (Toyama, Japan) were used for detection of LMP1 and CD63.
Specimens were from 18 men and 2 women, aged 43–78 years (mean 58.5
years) and classified histologically as follows: 1 keratinizing carcinoma, 12
nonkeratinizing carcinoma (type II), and 7 undifferentiated carcinoma (type
III) (Fifth TNM classification system of the International Union Against
Cancer (1997)). Primary antibody for CD63 was the same as used for
western blotting. Mouse LMP1 antibody was from DAKO (Glostrup,
Denmark). Stained samples of CD63 and LMP1 were evaluated as follows:
under light microscopy, two areas that showed high densities of stained
cells were selected in a × 40 field. The number of stained cells among 200
cells was then carefully counted in two areas in a × 200 field without
knowledge of clinicopathological status. Percentages of positive cells
obtained as an average of two counts were used as expression scores for
both proteins.
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